InMed Pharmaceuticals Inc (IN)

$0.24CAD

+$0.24 (+24.00%)

today (15 min delay)

About IN

InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

CEO

Eric A. Adams

Headquarters

Canada

Employees

12

Revenue (TTM)

0

Gross Profit

Earnings

-47.00%

Cash

$14.7M

Debt

$504K

IN related news

    Popular on Wealthsimple

      Investing on autopilot

      Invest in an intelligent portfolio of low-fee funds that are designed to meet your financial goals.

      • Low Fees - Pay an annual management fee of 0.50% (or 0.40% for accounts over $100K)

      • Stay on track - We'll instantly rebalance your portfolio and put your stock dividends back to work, earning you more

      • Human advice - We're loved for our technology. But we also have smart people to answer any questions or give advice when you need it.

      • Easy access - Manage your accounts from anywhere with our award-winning website and mobile app

      Clock

      Start investing in 5 minutes

      1. Answer a few questions about your goals and risk tolerance
      2. We'll recommend a portfolio that's right for you
      3. Connect your bank account and make a deposit

      Clicking get started accepts terms of use.